| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/04/2008 | CN101190232A Magnesium isoglycyrrhizinate freeze dried powder injection for injection and preparation method thereof |
| 06/04/2008 | CN101190231A Bykomycin chewable tablets for dog or cat |
| 06/04/2008 | CN101190230A Doxycycline hydrochloride chewable tablets for dog or cat |
| 06/04/2008 | CN101190219A Phthalyl sulfathiazol tablet chewable tablets for dog or cat |
| 06/04/2008 | CN101190217A Amoxicillin clavulanate potassium 4:1 dispersible tablet and production technology thereof |
| 06/04/2008 | CN101190211A Application of aromatic nitro compound in preparing medicine for treating virus hepatitis |
| 06/04/2008 | CN101190205A Ribavirin dissolvable tablet for infant |
| 06/04/2008 | CN101190194A Enrofloxacin chewable tablets for dog or cat |
| 06/04/2008 | CN101190190A Ursocycline chewable tablets for dog or cat |
| 06/04/2008 | CN101190181A Monomer nano silver sanitary tampon and preparation method thereof |
| 06/04/2008 | CN101190178A Antiviral partial film forming gel composition |
| 06/04/2008 | CN101189999A Persimmon leaf health tea |
| 06/04/2008 | CN100392087C Flavivirus vaccine delivery system |
| 06/04/2008 | CN100392085C Vaccines |
| 06/04/2008 | CN100392082C Conserved neisserial antigens |
| 06/04/2008 | CN100392067C Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents |
| 06/04/2008 | CN100391975C Human source anti- tetanus exotoxin antibody and preparation method and use thereof |
| 06/04/2008 | CN100391969C Helicobacter Pylori urease B subunit Th epitope peptide, its coding DNA, vaccine and uses |
| 06/04/2008 | CN100391967C Hepatitis C tripeptide inhibitors |
| 06/04/2008 | CN100391930C 1, 3-propane diol derivatives as bioactive compounds |
| 06/04/2008 | CN100391544C The E type DNA vaccine of Chlamydi trachomatis and its preparation methods and applications |
| 06/04/2008 | CN100391543C Non-viral gene delivery system |
| 06/04/2008 | CN100391542C Composition for delivering genes to antigen presenting cells of the skin and its use |
| 06/04/2008 | CN100391537C Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B |
| 06/04/2008 | CN100391536C Therapeutic vaccine composition for hepatitis B |
| 06/04/2008 | CN100391520C Medicine for treating herpes of genitals |
| 06/04/2008 | CN100391469C Remedies for hepatitis C |
| 06/04/2008 | CN100391465C Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic |
| 06/04/2008 | CN100391456C Beta-cyclodextrin / amoxicillin inclusion compound and its composition with clavulanic kalium and preparation method thereof |
| 06/04/2008 | CN100391455C Use of isatin and oxindole derivatives in preparing medicine |
| 06/04/2008 | CN100391449C Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 06/04/2008 | CN100391446C Method of rearing and feeds |
| 06/04/2008 | CN100391441C Matrine elaioplast drop ball and its preparation method |
| 06/04/2008 | CN100391439C Immunopotentiators |
| 06/04/2008 | CN100391430C Health care towel for health of feet |
| 06/03/2008 | US7381807 Of given nucleotide sequence; encapsulated in slow release delivery vehicle; includes viral or bacterial antigen; increases cell proliferation, differentiation, cytokine and antibody production for lymphocytes |
| 06/03/2008 | US7381795 Modified interferon beta with reduced immunogenicity |
| 06/03/2008 | US7381790 Copolymers for suppression of autoimmune diseases, and methods of use |
| 06/03/2008 | US7381704 Methods for use of short bioactive peptides |
| 06/03/2008 | US7381521 Anti-pathogenic composition useful in blood preservation |
| 06/03/2008 | US7381435 Composition for treating hepatitis C |
| 06/03/2008 | US7381430 Prepared from Geranium, Root of Membranous Milkvetch, Herba Solani Nigri, Honeysuckle Flower, Flower of Common Bombax, Fruit of Belleric Terminalia, Herba Hedyotis Diffusae, Pomegranate Rind, Radix Oryzae, and Fructus Trapae; treating Acquired Immune Deficiency Syndrome |
| 06/03/2008 | US7381411 Preventing influenza virus cell binding; schizophrenia; diagnosing chronic viral disease associated with cancer development |
| 06/03/2008 | US7381406 Probiotic lactobacillus strains for pets |
| 06/03/2008 | CA2558659C Genetically engineered canary poxvirus-based vaccine strain |
| 06/03/2008 | CA2313024C Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 06/03/2008 | CA2279846C Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 06/03/2008 | CA2160016C Method of forming oligonucleotides |
| 06/03/2008 | CA2134835C Live in ovo vaccine |
| 05/29/2008 | WO2008064311A2 Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties |
| 05/29/2008 | WO2008064066A1 Hepatitis c virus inhibitors |
| 05/29/2008 | WO2008064061A1 Macrocyclic peptides as hepatitis c virus inhibitors |
| 05/29/2008 | WO2008064057A1 Macrocyclic peptides as hepatitis c virus inhibitors |
| 05/29/2008 | WO2008063600A2 Triazolyl tropane derivatives |
| 05/29/2008 | WO2008062861A1 Extract powder of indigo-containing plant, method for production thereof, and use thereof |
| 05/29/2008 | WO2008062574A1 Sugar derivative and use thereof |
| 05/29/2008 | WO2008062206A2 Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus |
| 05/29/2008 | WO2008062167A2 Melatonin derivatives and their use as antioxidants |
| 05/29/2008 | WO2008061400A1 Fatty acid synthase inhibitors and medical uses thereof |
| 05/29/2008 | WO2008061399A1 Fatty acid synthase inhibitor and its use |
| 05/29/2008 | WO2008061375A1 Antiseptic |
| 05/29/2008 | WO2008061306A1 Metal delivery agents and therapeutic uses of the same |
| 05/29/2008 | WO2008045673A3 Quinolone carboxylic acids, derivatives thereof, processes for its preparation and its use as antibacterial agents |
| 05/29/2008 | WO2008045507A3 Substituted tetracycline compounds for treatment of bacillus anthracis infections |
| 05/29/2008 | WO2008021927A3 Hepatitis c virus inhibitors |
| 05/29/2008 | WO2008016123A1 GSK-3β INHIBITOR |
| 05/29/2008 | WO2008012440A3 Pyridazine and pyrrole compounds, processes for obtaining them and uses |
| 05/29/2008 | WO2008009655A3 Medical use of n-phenylpropenoyl-amino acid derivatives and related compounds |
| 05/29/2008 | WO2008008841A3 Use of benzimidazole derivatives for the treatment and/or prevention of autoimmune disorders |
| 05/29/2008 | WO2007141158A3 Isolated extract of walnuts, process for its obtention and its use |
| 05/29/2008 | WO2007136719A3 Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof |
| 05/29/2008 | WO2007111998A3 Dsrna compositions and methods for treating hpv infection |
| 05/29/2008 | WO2007074456A3 Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids |
| 05/29/2008 | WO2007071453A8 Organophosphoric derivatives useful as anti-parasitic agents |
| 05/29/2008 | WO2007042884A9 Vaccines and methods to treat canine influenza |
| 05/29/2008 | US20080125498 Treatment of neurodegenerative diseases and conditions using par1 antagonists |
| 05/29/2008 | US20080125496 Antimicrobial flavor and oral care composition containing the same |
| 05/29/2008 | US20080125484 Synthetic Lactone Formulations and Methods of Use |
| 05/29/2008 | US20080125477 7-(acryloyl) indole compositions and methods of making and using same |
| 05/29/2008 | US20080125460 inducible nitric oxide synthase inhibitors; acute or chronic inflammatory diseases of of peripheral organs and the central nervous system; 6-pyridinyl imidazo-[4,5-b]pyridine compounds; 2-[2-(4-Methoxypyridin-2-yl)ethyl]-6-(pyridin-4-yl)-3H-imidazo-[4,5-b]pyridine |
| 05/29/2008 | US20080125458 Pradofloxacin trihydrate; thermodynamically stable and is not converted to other crystal forms even during prolonged storage; non-hygroscopic |
| 05/29/2008 | US20080125446 For example, 6-amino-2-(chloro or fluoro)-8-(arylthio(oxo))-9H-purines; complex with Heat Shock Protein 90 (HSP 90); proliferative disorders such as breast cancer |
| 05/29/2008 | US20080125444 Acyclic oximyl hepatitis c protease inhibitors |
| 05/29/2008 | US20080125439 Diazaindole-dicarbonyl-piperazinyl antiviral agents |
| 05/29/2008 | US20080125435 E. g., 1-(3-chloro-phenyl)-3-[1-(7-chloro-quinolin-4-yl)-piperidin-4-yl]-thiourea; regulation of ovulation, modulation of prostaglandin E2 receptors; fertilization, nidation, decidualization (e.g. placenta formation) and menstruation; hypermenorrhea, dysmenorrhea; endometriosis; anticarcinogenic agents |
| 05/29/2008 | US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 05/29/2008 | US20080125408 (5-propyl-2-oxo-1,3-dioxol-4-yl)methyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[[(1R,3S)-tetrahydro-1-oxido-3-thienyl]thio]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate for teating bacterial infections such as bronchitis, sinusitis, otitis media, brain abscess, pneumonia etc; oral bioavailability |
| 05/29/2008 | US20080125376 Viricide against hepatitis virus; pyrrole derivatives as, for example, 3-acetyl-4,5-dimethyl-2-pyrrole carboxylic acid |
| 05/29/2008 | US20080125375 Peptide like compounds for treating coronavirus or aviviridae virus; severe acute respiratory distress syndrome |
| 05/29/2008 | US20080125370 Preventing grampositive bacterial infection via upregulation of interleukin expression and down-regulating pro-inflammatory cytokine expression; sepsis |
| 05/29/2008 | US20080125369 Soluble t cell receptors |
| 05/29/2008 | US20080125365 Fibronectins; inflammation |
| 05/29/2008 | US20080124743 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (u1) |
| 05/29/2008 | US20080124390 Antidepressants for treating manic disorders, psychosis; comprising ethyl cellulose, talc, polyvinylpyrrolidone; time-release dosage form; once daily |
| 05/29/2008 | US20080124384 Heteroaryl Substituted Piperazinyl-Pyridine Analogues |
| 05/29/2008 | US20080124377 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 05/29/2008 | US20080124358 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 05/29/2008 | US20080124353 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/29/2008 | US20080124351 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/29/2008 | US20080124337 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics |